JP2019017393A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019017393A5 JP2019017393A5 JP2018193565A JP2018193565A JP2019017393A5 JP 2019017393 A5 JP2019017393 A5 JP 2019017393A5 JP 2018193565 A JP2018193565 A JP 2018193565A JP 2018193565 A JP2018193565 A JP 2018193565A JP 2019017393 A5 JP2019017393 A5 JP 2019017393A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell culture
- medium
- biomatrix scaffold
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims description 94
- 238000000034 method Methods 0.000 claims description 81
- 210000001519 tissue Anatomy 0.000 claims description 57
- 210000000130 stem cell Anatomy 0.000 claims description 47
- 238000004519 manufacturing process Methods 0.000 claims description 33
- 238000004113 cell culture Methods 0.000 claims description 30
- 239000002609 medium Substances 0.000 claims description 26
- 239000006143 cell culture medium Substances 0.000 claims description 25
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- 210000004881 tumor cell Anatomy 0.000 claims description 17
- 241000700605 Viruses Species 0.000 claims description 16
- 238000010899 nucleation Methods 0.000 claims description 14
- 239000000758 substrate Substances 0.000 claims description 14
- 239000000872 buffer Substances 0.000 claims description 13
- 230000004069 differentiation Effects 0.000 claims description 13
- 102000008186 Collagen Human genes 0.000 claims description 12
- 108010035532 Collagen Proteins 0.000 claims description 12
- 229920001436 collagen Polymers 0.000 claims description 12
- 230000001419 dependent effect Effects 0.000 claims description 10
- 239000003599 detergent Substances 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 230000007935 neutral effect Effects 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 239000012980 RPMI-1640 medium Substances 0.000 claims description 8
- 210000004381 amniotic fluid Anatomy 0.000 claims description 7
- 239000007640 basal medium Substances 0.000 claims description 7
- 210000000013 bile duct Anatomy 0.000 claims description 7
- 239000011159 matrix material Substances 0.000 claims description 7
- 230000001737 promoting effect Effects 0.000 claims description 7
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 230000009984 peri-natal effect Effects 0.000 claims description 6
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 claims description 5
- 210000005229 liver cell Anatomy 0.000 claims description 5
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 102000004127 Cytokines Human genes 0.000 claims description 4
- 108090000695 Cytokines Proteins 0.000 claims description 4
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims description 4
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 4
- 210000003722 extracellular fluid Anatomy 0.000 claims description 4
- 239000003102 growth factor Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 239000004367 Lipase Substances 0.000 claims description 3
- 102000004882 Lipase Human genes 0.000 claims description 3
- 108090001060 Lipase Proteins 0.000 claims description 3
- 210000000941 bile Anatomy 0.000 claims description 3
- 210000002889 endothelial cell Anatomy 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 239000000122 growth hormone Substances 0.000 claims description 3
- 210000003494 hepatocyte Anatomy 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims description 3
- 235000019421 lipase Nutrition 0.000 claims description 3
- 210000004738 parenchymal cell Anatomy 0.000 claims description 3
- 210000004500 stellate cell Anatomy 0.000 claims description 3
- 241000711549 Hepacivirus C Species 0.000 claims description 2
- 241000700721 Hepatitis B virus Species 0.000 claims description 2
- 241000701806 Human papillomavirus Species 0.000 claims description 2
- 241001263478 Norovirus Species 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 229960003964 deoxycholic acid Drugs 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 210000004072 lung Anatomy 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 claims description 2
- 210000001685 thyroid gland Anatomy 0.000 claims description 2
- -1 sorbitan ester Chemical class 0.000 claims 3
- 230000035755 proliferation Effects 0.000 claims 2
- 230000001052 transient effect Effects 0.000 claims 2
- JDRSMPFHFNXQRB-LJIZCISZSA-N (2s,3r,4s,5s,6r)-2-decoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CCCCCCCCCCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-LJIZCISZSA-N 0.000 claims 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims 1
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 1
- 210000000702 aorta abdominal Anatomy 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 239000012459 cleaning agent Substances 0.000 claims 1
- WOQQAWHSKSSAGF-WXFJLFHKSA-N decyl beta-D-maltopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](OCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 WOQQAWHSKSSAGF-WXFJLFHKSA-N 0.000 claims 1
- NLEBIOOXCVAHBD-QKMCSOCLSA-N dodecyl beta-D-maltoside Chemical compound O[C@@H]1[C@@H](O)[C@H](OCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NLEBIOOXCVAHBD-QKMCSOCLSA-N 0.000 claims 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical group CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 claims 1
- 229940043264 dodecyl sulfate Drugs 0.000 claims 1
- 210000001198 duodenum Anatomy 0.000 claims 1
- 210000002216 heart Anatomy 0.000 claims 1
- 210000003111 iliac vein Anatomy 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 claims 1
- JDRSMPFHFNXQRB-UHFFFAOYSA-N n-decyl-alpha-D-glucopyranoside Natural products CCCCCCCCCCOC1OC(CO)C(O)C(O)C1O JDRSMPFHFNXQRB-UHFFFAOYSA-N 0.000 claims 1
- HEGSGKPQLMEBJL-UHFFFAOYSA-N n-octyl beta-D-glucopyranoside Natural products CCCCCCCCOC1OC(CO)C(O)C(O)C1O HEGSGKPQLMEBJL-UHFFFAOYSA-N 0.000 claims 1
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 claims 1
- 210000000496 pancreas Anatomy 0.000 claims 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 1
- 229920001993 poloxamer 188 Polymers 0.000 claims 1
- 229940044519 poloxamer 188 Drugs 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 1
- 235000011152 sodium sulphate Nutrition 0.000 claims 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims 1
- 210000003932 urinary bladder Anatomy 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 210000002220 organoid Anatomy 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 229940122618 Trypsin inhibitor Drugs 0.000 description 2
- 101710162629 Trypsin inhibitor Proteins 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 230000001394 metastastic effect Effects 0.000 description 2
- 206010061289 metastatic neoplasm Diseases 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 108010008217 nidogen Proteins 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 239000002753 trypsin inhibitor Substances 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 102100037611 Lysophospholipase Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102100037369 Nidogen-1 Human genes 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000005068 bladder tissue Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 210000001654 germ layer Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004565 tumor cell growth Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36093910P | 2010-07-02 | 2010-07-02 | |
| US61/360,939 | 2010-07-02 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016237356A Division JP6612722B2 (ja) | 2010-07-02 | 2016-12-07 | バイオマトリックス足場 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019017393A JP2019017393A (ja) | 2019-02-07 |
| JP2019017393A5 true JP2019017393A5 (enExample) | 2019-08-08 |
Family
ID=45402468
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013518763A Pending JP2013539960A (ja) | 2010-07-02 | 2011-07-01 | 工業規模の散布のためのバイオマトリックス足場 |
| JP2013518758A Expired - Fee Related JP6308781B2 (ja) | 2010-07-02 | 2011-07-01 | バイオマトリックス足場 |
| JP2016237356A Expired - Fee Related JP6612722B2 (ja) | 2010-07-02 | 2016-12-07 | バイオマトリックス足場 |
| JP2016237355A Pending JP2017055764A (ja) | 2010-07-02 | 2016-12-07 | 工業規模の散布のためのバイオマトリックス足場 |
| JP2018102418A Expired - Fee Related JP6527272B2 (ja) | 2010-07-02 | 2018-05-29 | 工業規模の散布のためのバイオマトリックス足場 |
| JP2018193545A Pending JP2019017392A (ja) | 2010-07-02 | 2018-10-12 | 工業規模の散布のためのバイオマトリックス足場 |
| JP2018193565A Pending JP2019017393A (ja) | 2010-07-02 | 2018-10-12 | バイオマトリックス足場 |
Family Applications Before (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013518763A Pending JP2013539960A (ja) | 2010-07-02 | 2011-07-01 | 工業規模の散布のためのバイオマトリックス足場 |
| JP2013518758A Expired - Fee Related JP6308781B2 (ja) | 2010-07-02 | 2011-07-01 | バイオマトリックス足場 |
| JP2016237356A Expired - Fee Related JP6612722B2 (ja) | 2010-07-02 | 2016-12-07 | バイオマトリックス足場 |
| JP2016237355A Pending JP2017055764A (ja) | 2010-07-02 | 2016-12-07 | 工業規模の散布のためのバイオマトリックス足場 |
| JP2018102418A Expired - Fee Related JP6527272B2 (ja) | 2010-07-02 | 2018-05-29 | 工業規模の散布のためのバイオマトリックス足場 |
| JP2018193545A Pending JP2019017392A (ja) | 2010-07-02 | 2018-10-12 | 工業規模の散布のためのバイオマトリックス足場 |
Country Status (11)
| Country | Link |
|---|---|
| US (7) | US8802081B2 (enExample) |
| EP (6) | EP2588027B8 (enExample) |
| JP (7) | JP2013539960A (enExample) |
| CN (4) | CN105713868A (enExample) |
| DK (2) | DK2588027T3 (enExample) |
| ES (6) | ES2946590T3 (enExample) |
| HU (2) | HUE032727T2 (enExample) |
| LT (2) | LT2588027T (enExample) |
| PL (2) | PL2588083T3 (enExample) |
| PT (2) | PT2588083T (enExample) |
| WO (2) | WO2012003450A2 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2946590T3 (es) * | 2010-07-02 | 2023-07-21 | Univ North Carolina Chapel Hill | Andamios de biomatriz para dispersión a escala industrial |
| NL2009145C2 (en) * | 2012-07-06 | 2014-01-07 | Xeltis B V | Implant. |
| CN103536967B (zh) * | 2012-07-10 | 2016-04-13 | 上海微创医疗器械（集团）有限公司 | 一种制备细胞外基质支架材料的脱细胞方法 |
| US9533013B2 (en) | 2013-03-13 | 2017-01-03 | University Of North Carolina At Chapel Hill | Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree |
| CN105164250A (zh) | 2013-03-15 | 2015-12-16 | 米罗马特里克斯医疗公司 | 灌注脱细胞化的肝脏在胰岛细胞再细胞化中的用途 |
| DK2968418T3 (da) * | 2013-03-15 | 2024-01-15 | Nutech Medical Inc | Præparater afledt af placentamaterialer til fremstilling og anvendelse deraf |
| HUE042704T2 (hu) * | 2013-04-08 | 2019-07-29 | Regentys Corp | Eljárás és készítmény gyulladásos bélbetegség kezelésére kolektómia nélkül |
| MX2016001247A (es) | 2013-07-30 | 2016-08-17 | Musculoskeletal Transplant Foundation | Matrices derivadas de tejido suave acelular y metodos para preparar las mismas. |
| CN103432627B (zh) * | 2013-08-26 | 2015-03-25 | 北京瑞健高科生物科技有限公司 | 一种制备动物脱细胞组织基质材料的方法及其制备的组织基质材料 |
| CA2944181C (en) | 2014-03-27 | 2019-09-17 | Salk Institute For Biological Studies | Compositions and methods for treating type 1 and type 2 diabetes and related disorders |
| GB201409858D0 (en) * | 2014-06-03 | 2014-07-16 | Ucl Business Plc | Human liver scaffolds |
| CN104288837B (zh) * | 2014-09-11 | 2016-04-13 | 杨淑珍 | 一种脱细胞真皮基质及其制备方法和用途 |
| EP3262157A4 (en) | 2015-02-27 | 2018-12-05 | Salk Institute for Biological Studies | Reprogramming progenitor compositions and methods of use therefore |
| CN104928241B (zh) * | 2015-03-27 | 2018-04-13 | 北京康爱瑞浩生物科技股份有限公司 | 一种增强型nk细胞的活化方法及细胞制备方法 |
| US10683484B2 (en) * | 2015-06-12 | 2020-06-16 | National University Of Singapore | Derivation of hepatic stem cells and mature liver cell types and uses thereof |
| US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
| CN106884002B (zh) * | 2015-12-15 | 2021-03-19 | 上海市针灸经络研究所 | 一种稳定的结肠上皮细胞培养方法 |
| CN105833353B (zh) * | 2016-05-09 | 2018-04-20 | 拜欧迪赛尔（北京）生物科技有限公司 | 一种生物工程脱细胞真皮基质的制备及用途 |
| US20170369849A1 (en) * | 2016-05-11 | 2017-12-28 | The University Of North Carolina At Chapel Hill | Compositions and methods for bioengineered tissues |
| EP3936610A1 (en) | 2016-05-25 | 2022-01-12 | Salk Institute for Biological Studies | Compositions and methods for organoid generation and disease modeling |
| CA3030166A1 (en) * | 2016-07-12 | 2018-01-18 | The University Of North Carolina At Chapel Hill | Biomatrix scaffolds for use in diagnosing and modeling cancer |
| CN106362212A (zh) * | 2016-10-21 | 2017-02-01 | 华中科技大学同济医学院附属协和医院 | 一种用于去除组织细胞的亲脂性去细胞溶液、试剂盒和方法 |
| GB2555787A (en) * | 2016-11-07 | 2018-05-16 | Landberg Goran | Diagnostic methods |
| EP3548895B1 (de) * | 2016-11-30 | 2024-07-03 | Bruker Daltonics GmbH & Co. KG | Aufbereitung lebendiger, mikrobieller proben und mikroorganismen für anschliessende massenspektrometrische messung und auswertung |
| CA3066710A1 (en) * | 2017-06-12 | 2018-12-20 | The University Of North Carolina At Chapel Hill | Patch graft compositions for cell engraftment |
| JP2020529267A (ja) * | 2017-07-31 | 2020-10-08 | ドゥ カント ザゴ, アレシャンドリDO CANTO ZAGO, Alexandre | 迅速なストラットの被覆および血管内皮の被覆を促進するためのデバイスおよび方法 |
| EP3470096A1 (en) * | 2017-10-13 | 2019-04-17 | Erasmus University Medical Center Rotterdam | Elastin reduction allowing recellularization of cartilage implants |
| WO2019129646A1 (en) * | 2017-12-29 | 2019-07-04 | F. Hoffmann-La Roche Ag | Tissue sample preparation system |
| WO2019222170A1 (en) * | 2018-05-14 | 2019-11-21 | Roosterbio, Inc. | Methods and compositions related to extracellular material derived from hypertonic cell solutions |
| WO2019241499A1 (en) | 2018-06-13 | 2019-12-19 | Miromatrix Medical Inc. | Fistula filler and deployment system |
| CN108753686B (zh) * | 2018-06-22 | 2021-06-22 | 中国人民解放军军事科学院军事医学研究院 | 组织工程肝脏模型、其构建方法及其应用 |
| CN108753687B (zh) * | 2018-06-22 | 2021-04-16 | 中国人民解放军军事科学院军事医学研究院 | 微肝组织培养模型、其构建方法及其应用 |
| CN109735490A (zh) * | 2019-03-06 | 2019-05-10 | 福建省海西细胞生物工程有限公司 | 一种脂肪干细胞提取方法 |
| CN110257335B (zh) * | 2019-04-10 | 2020-09-29 | 首都医科大学附属北京天坛医院 | 单层或多层的3d脑胶质瘤细胞培养模型及其构建方法和应用 |
| JP7547383B2 (ja) | 2019-05-16 | 2024-09-09 | レスメド・プロプライエタリー・リミテッド | 医療デバイスにおける双方向通信 |
| WO2021045373A1 (ko) * | 2019-09-04 | 2021-03-11 | 한국생명공학연구원 | 증식 가능한 간 오가노이드 |
| CN110559485B (zh) * | 2019-09-25 | 2021-02-02 | 北京大清生物技术股份有限公司 | 一种生物组织基质材料及其制备方法与应用 |
| DE102019130568A1 (de) | 2019-11-13 | 2021-05-20 | Aesculap Ag | Chirurgischer Fräser mit verbesserter Spanabfuhr |
| CN111110919A (zh) * | 2019-12-30 | 2020-05-08 | 广东泓志生物科技有限公司 | 大网膜脱细胞基质材料的制备方法及软骨组织的构建方法 |
| JP7623017B2 (ja) * | 2020-02-14 | 2025-01-28 | セルアートジェン インコーポレイテッド | 臓器オルガノイドの培養及び移植のための脱細胞臓器組織由来の支持体及びその製造方法 |
| CN111760072B (zh) * | 2020-08-24 | 2022-09-23 | 鲁峰 | 脂肪来源的真皮内填充物及其制备和应用 |
| CN114748208B (zh) * | 2022-04-15 | 2024-01-12 | 柔脉医疗(深圳)有限公司 | 一种可原位检测多种化学、生物成分的组织工程支架 |
| CN115948331B (zh) * | 2022-10-17 | 2024-10-22 | 中国人民解放军西部战区总医院 | 一种从小鼠胆囊中分离获取间充质干细胞的方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19569C (de) | ANNA ERBER in Brieg | Neuerungen an der unter Nr. 17581 patentirten Handlaterne | ||
| CA2155186A1 (en) | 1993-02-01 | 1994-08-18 | Kevin M. Ulmer | Methods and apparatus for dna sequencing |
| US5695998A (en) * | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
| US6149891A (en) * | 1995-05-31 | 2000-11-21 | Israel Humanitarian Foundation Ltd. | X-ray contrast medium and method for protecting against harmful effects thereof |
| US20020177551A1 (en) | 2000-05-31 | 2002-11-28 | Terman David S. | Compositions and methods for treatment of neoplastic disease |
| DE60121450T2 (de) * | 2000-08-16 | 2007-02-15 | Duke University | Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe |
| AU2002243980B2 (en) * | 2001-02-14 | 2007-08-23 | Robert J. Hariri | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
| EP1404388B1 (en) | 2001-06-28 | 2013-10-23 | Cook Biotech, Inc. | Graft prosthesis devices containing renal capsule collagen |
| US20040187877A1 (en) * | 2002-12-04 | 2004-09-30 | Badylak Stephen F. | Method for repair of liver tissue |
| CN100412188C (zh) * | 2003-02-21 | 2008-08-20 | Uab研究基金会 | 生物活性天然生物基质组合物 |
| WO2005002601A1 (en) | 2003-06-25 | 2005-01-13 | Badylak Stephen F | Conditioned matrix compositions for tissue restoration |
| AU2004252568B2 (en) * | 2003-06-27 | 2011-06-30 | Ethicon, Incorporated | Regeneration and repair of neural tissue using postpartum-derived cells |
| MX2007015541A (es) * | 2005-06-10 | 2008-03-06 | Celgene Corp | Composiciones de colageno de placenta humana proceso para su preparacion, metodos de uso y equipos que contienen las composiciones. |
| WO2007018165A1 (ja) * | 2005-08-10 | 2007-02-15 | Toray Industries, Inc. | スポンジ状構造体および粉末、ならびにそれらの製造方法 |
| US9944900B2 (en) | 2006-01-18 | 2018-04-17 | Hemacell Perfusion | Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells |
| US8241908B2 (en) * | 2006-05-16 | 2012-08-14 | Becton, Dickinson And Company | Extracellular matrix coated surface for culturing cells |
| US8685107B2 (en) | 2007-07-03 | 2014-04-01 | Histogenics Corporation | Double-structured tissue implant and a method for preparation and use thereof |
| CN106178118A (zh) * | 2008-09-30 | 2016-12-07 | 加利福尼亚大学董事会 | 用于组织修复的使用细胞外基质的组合物和方法 |
| US20120064050A1 (en) * | 2009-02-04 | 2012-03-15 | Yale University | Tissue Engineering of Lung |
| US9277999B2 (en) * | 2009-02-27 | 2016-03-08 | University of Pittsburgh—of the Commonwealth System of Higher Education | Joint bioscaffolds |
| ES2650450T3 (es) * | 2010-06-30 | 2018-01-18 | Miromatrix Medical Inc. | Uso de órganos descelularizados por perfusión para recelularización adaptada |
| ES2946590T3 (es) * | 2010-07-02 | 2023-07-21 | Univ North Carolina Chapel Hill | Andamios de biomatriz para dispersión a escala industrial |
-
2011
- 2011-07-01 ES ES19199017T patent/ES2946590T3/es active Active
- 2011-07-01 EP EP11801504.9A patent/EP2588027B8/en not_active Not-in-force
- 2011-07-01 WO PCT/US2011/042805 patent/WO2012003450A2/en not_active Ceased
- 2011-07-01 CN CN201510751844.4A patent/CN105713868A/zh active Pending
- 2011-07-01 JP JP2013518763A patent/JP2013539960A/ja active Pending
- 2011-07-01 EP EP16191501.2A patent/EP3192862B1/en active Active
- 2011-07-01 DK DK11801504.9T patent/DK2588027T3/en active
- 2011-07-01 CN CN201180042690.1A patent/CN103491898B/zh not_active Expired - Fee Related
- 2011-07-01 EP EP19199017.5A patent/EP3603622B1/en active Active
- 2011-07-01 PT PT118014935T patent/PT2588083T/pt unknown
- 2011-07-01 DK DK11801493.5T patent/DK2588083T3/en active
- 2011-07-01 PL PL11801493T patent/PL2588083T3/pl unknown
- 2011-07-01 EP EP11801493.5A patent/EP2588083B1/en not_active Not-in-force
- 2011-07-01 HU HUE11801504A patent/HUE032727T2/en unknown
- 2011-07-01 CN CN201610286180.3A patent/CN106362211A/zh active Pending
- 2011-07-01 ES ES11801493.5T patent/ES2624742T3/es active Active
- 2011-07-01 ES ES16191501T patent/ES2879246T3/es active Active
- 2011-07-01 ES ES19174054T patent/ES2916580T3/es active Active
- 2011-07-01 US US13/807,253 patent/US8802081B2/en active Active
- 2011-07-01 PT PT118015049T patent/PT2588027T/pt unknown
- 2011-07-01 HU HUE11801493A patent/HUE032730T2/en unknown
- 2011-07-01 EP EP19174054.7A patent/EP3581171B1/en not_active Not-in-force
- 2011-07-01 PL PL11801504T patent/PL2588027T3/pl unknown
- 2011-07-01 CN CN2011800426899A patent/CN103249404A/zh active Pending
- 2011-07-01 US US13/807,260 patent/US9102913B2/en active Active
- 2011-07-01 ES ES11801504.9T patent/ES2626145T3/es active Active
- 2011-07-01 JP JP2013518758A patent/JP6308781B2/ja not_active Expired - Fee Related
- 2011-07-01 EP EP16191506.1A patent/EP3216444B1/en active Active
- 2011-07-01 LT LTEP11801504.9T patent/LT2588027T/lt unknown
- 2011-07-01 LT LTEP11801493.5T patent/LT2588083T/lt unknown
- 2011-07-01 WO PCT/US2011/042825 patent/WO2012003463A1/en not_active Ceased
- 2011-07-01 ES ES16191506T patent/ES2791312T3/es active Active
-
2014
- 2014-08-08 US US14/455,819 patent/US20150110753A1/en not_active Abandoned
-
2015
- 2015-10-13 US US14/813,993 patent/US9944896B2/en active Active
-
2016
- 2016-07-27 US US15/221,413 patent/US10246678B2/en active Active
- 2016-12-07 JP JP2016237356A patent/JP6612722B2/ja not_active Expired - Fee Related
- 2016-12-07 JP JP2016237355A patent/JP2017055764A/ja active Pending
-
2018
- 2018-04-12 US US15/952,094 patent/US10640747B2/en not_active Expired - Fee Related
- 2018-05-29 JP JP2018102418A patent/JP6527272B2/ja not_active Expired - Fee Related
- 2018-10-12 JP JP2018193545A patent/JP2019017392A/ja active Pending
- 2018-10-12 JP JP2018193565A patent/JP2019017393A/ja active Pending
-
2019
- 2019-02-12 US US16/274,020 patent/US20200002667A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019017393A5 (enExample) | ||
| Tian et al. | Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold for bladder tissue engineering | |
| Watson et al. | Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells | |
| Gridelli et al. | Efficient human fetal liver cell isolation protocol based on vascular perfusion for liver cell–based therapy and case report on cell transplantation | |
| JP6890549B2 (ja) | 間葉系幹細胞の製造方法 | |
| CN104099290A (zh) | 用胎盘细胞群治疗骨缺损的方法和组合物 | |
| CN103396990A (zh) | 一种制备间充质干细胞的方法 | |
| JP2015061520A (ja) | 羊膜間葉系細胞組成物の製造方法及び凍結保存方法、並びに治療剤 | |
| JP6931656B2 (ja) | クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞 | |
| CN107635592A (zh) | 充气的去细胞化胞外基质 | |
| CN103070161A (zh) | 一种脂肪间充质干细胞冻存液及冻存方法 | |
| JP6193214B2 (ja) | 歯髄由来の多能性幹細胞の製造方法 | |
| CN108753686B (zh) | 组织工程肝脏模型、其构建方法及其应用 | |
| AU2014203616B2 (en) | Mammary artery derived cells and methods of use in tissue repair and regeneration | |
| Zhu et al. | Evaluating the efficacy of dedifferentiated fat cells (DFATs) vs adipose-derived stem cells (ASCs) in enhancing the viability of fat grafts | |
| EP3381458B1 (en) | Therapeutic agent for liver disease containing stromal cells derived from adipose tissue and method for producing the same | |
| WO2009080794A1 (en) | Method for preparing cell-specific extracellular matrices | |
| Zhu et al. | Human Umbilical Cord Mesenchymal Stem Cells' Cultivation and Treatment of Liver Diseases | |
| CN106701670A (zh) | 一种增强间充质干细胞分泌生物活性因子能力及培养液中活性因子的提取方法 | |
| Ghufran et al. | Adipose tissue and umbilical cord tissue: potential sources of mesenchymal stem cells for liver fibrosis treatment | |
| CN102161981B (zh) | 一种重组蛋白联合诱导骨髓间充质干细胞转变为汗腺细胞的方法 | |
| CN105456293A (zh) | 一种用于治疗糖尿病的干细胞制剂及其制备方法 | |
| JP2024112404A (ja) | 間葉系幹細胞の培養方法 | |
| JP5960777B2 (ja) | 関節疾患を治療するための組成物及び方法 | |
| Sheykhhasan et al. | Isolation and maintenance of canine Adipose-Derived Mesenchymal Stem Cells in order to tissue engineering application |